Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 influenza A virus induces protective immunity in mice

Clinical and Vaccine Immunology

Volumn 18, Issue 9, 2011, Pages 1582-1585

  Prabakaran, Mookkan ^a   Meng, Tao ^a   He, Fang ^a   YunRui, Tan ^a   Qiang, Jia ^a   Lin, Raymond Tzer Pin ^b   Kwang, Jimmy ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MINISTRY OF HEALTH   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INACTIVATED VIRUS VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; LIVE VACCINE;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; INFLUENZA VACCINATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; WHITE SPOT SYNDROME VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELLS, CULTURED; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; RECOMBINATION, GENETIC; SPODOPTERA; VACCINES, INACTIVATED;

EID: 80052460167     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05114-11     Document Type: Article

References (16)

1. Abe, T., et al. 2005. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J. Virol. 79:2847-2858. (Pubitemid 40270563)
2. Babiuk, L. A. 1999. Broadening the approaches to developing more effective vaccines. Vaccine 17:1587-1595. (Pubitemid 29138888)
3. Chung, E. Y., L. Huang, and L. Schneider. 2010. Safety of influenza vaccine administration in egg-allergic patients. Pediatrics 125:e1024-e1030.
4. King, D. J. 1991. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. Avian Dis. 35:505-514.
5. Madhan, S., M. Prabakaran, and J. Kwang. 2010. Baculovirus as vaccine vectors. Curr. Gene Ther. 10:201-213.
6. O'Reilly, D. R., L. K. Miller, and V. A. Luckow. 1992. Baculovirus expression vectors, a laboratory manual, p. 60-61. W. H. Freeman Company, New York, NY.
7. Prabakaran, M., S. Madhan, N. Prabhu, J. Qiang, and J. Kwang. 2010. Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection. J. Virol. 84:3201-3209.
8. Quan, F. S., A. Vunnava, R. W. Compans, and S. M. Kang. 2010. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One 5:e9161.
9. Rueda, P., et al. 2000. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 19:726-734.
10. Suguitan, A. L., Jr., et al. 2006. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross protection in mice and ferrets. PLoS Med. 3:e360.
11. Treanor, J. J., et al. 2001. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19:1732-1737. (Pubitemid 32175735)
12. Treanor, J. J., et al. 2007. Safety and immunogenicity of a baculovirus expressed hemagglutinin influenza vaccine. JAMA 297:1577-1582. (Pubitemid 46588371)
13. Treanor, J. 2009. Recombinant proteins produced in insect cells. Curr. Top. Microbiol. Immunol. 333:211-225.
14. Webster, R. G., Y. Kawaoka, J. Taylor, R. Weinberg, and E. Paoletti. 1991. Efficacy of nucleoprotein and hemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9:303-308.
15. World Health Organization. 2010. Pandemic (H1N1) 2009-update 100. World Health Organization, Geneva, Switzerland. http://www.who.int/csr /don/2010-08-06/en/index.html. Accessed 18 September 2010.
16. World Health Organization Global Influenza Program Surveillance Network. 2005. Evolution of H5N1 avian influenza viruses in Asia. Emerg. Infect. Dis. 11:1515-1521.